Biology Reference
In-Depth Information
thropoietin treatment in pre-dialysis end stage renal disease patients.
Nippon Jinzo Gakkai Shi
35:
1233-1242
35 Petersen J, Kang MS, Hays MT (1996) Erythropoietin can be administered during dialysis: A
kinetic analysis.
ASAIO J
42: 27-33
36 Bargman JM, Jones JE, Petro JM (1992) The pharmacokinetics of intraperitoneal erythropoietin
administered undiluted or diluted in dialysate.
Perit Dial Int
12: 369-372
37Taylor CA III, Kosorok MR, Zimmerman SW, Johnson CA (1999) Pharmacokinetics of intraperi-
toneal epoetin alfa in patients on peritoneal dialysis using an 8-hour “dry dwell” dosing technique.
Am J Kidney Dis
34: 657-662
38 Reddingius RE, Schroder CH, Koster AM, Monnens LA (1994) Pharmacokinetics of recombinant
human erythropoietin in children treated with continuous ambulatory peritoneal dialysis.
Eur J
Pediatr
153: 850-854
39 Evans JH, Brockleank JT, Bowmer CJ, Ng PC (1991) Pharmacokinetics of recombinant human
erythropoietin in children with renal failure.
Nephrol Dial Transplant
6:709-714
40 Montini G, Zacchello G, Perfumo F (1991) Pharmacokinetics and pharmacodynamis of subcuta-
neous administration of r-HuEPO on CPD. A multicenter study from the Italian Registry of
Pediatric CPD.
J Am Soc Nephrol
2: 283
41 Braun A, Ding R, Seidel C, Fies T, Kurtz A, Scharer K (1993) Pharmacokinetics of recombinant
human erythropoietin applied subcutaneously to children with chronic renal failure.
Pediatric
Nephrol
7: 61-64
42 Geva P, Sherwood JB (1991) Pharmacokinetics of recombinant human erythropoietin (rHuEPO)
in pediatric patients on chronic cycling peritoneal dialysis (CCPD).
Blood
78 (Suppl. 1): 91a
43Cakar N, Ekim M, Turner N, Yalcinkaya F, Akar N, Onaran HO (1997) Pharmacokinetics of
recombinant human erythropoietin in children with chronic renal failure.
Int Urol Nephrol
29:
377-383
44 Jabs K, Grant JR, Harmon W, Egrie JC (1991) Pharamcokinetics of Epoetin Alfa (rHuEPO) in
pediatric hemodialysis (HD) patients.
J Am Soc Nephrol
2: 380
45 Kausz AT, Watkins SL, Hansen C, Godwin DA, Palmer RB, Brandt JR (1999) Intraperitoneal ery-
thropoietin in children on peritoneal dialysis: A study of pharmacokinetics and efficacy.
Am J
Kidney Dis
34: 651-656
46 Jobs K, Grenda R, Gregorek H (1995) Pain relief and correct erythropoietin kinetics after Eprex
injection with EMLA (lignocaine-prilocaine cream) premedication in dialysed children.
Ann Acad
Med Gedanesis
25: 93-97
47 Canaparo R, Casale F, Muntoni E, Zara GP, Della Pepa C, Berno E, Pons N, Fornari G, Eandi M
(2000) Plasma erythropoietin concentrations in patients receiving intensive platinum or nonplat-
inum chemotherapy.
Br J Clin Pharmacol
50: 146-153
48Pedain C, Herrero J, Kunzel W (2001) Serum erythropoietin levels in ovarian cancer patients
receiving chemotherapy.
Eur J Obstet Gynecol Reprod Biol
98: 224-230
49 Franek E, Wiecek A, Kozielski J, Rauer R, Kokot M, Kokot F, Oklek K (1996) [Half-time of ery-
thropoietin in patients with chronic obstructive pulmonary diseases].
Przegl Lek
53: 592-594
50 Bowen D, Ehmer B, Neubert P, Lewis T, Jacobs A (1991) The clearance of a single i.v. bolus of
recombinant human erythropoietin from the serum of patients with myelodysplastic syndromes
and its effects on erythropoiesis.
Exp Hematol
19: 613-616
51 Macdougall IC, Jones JM, Robinson MI, Miles JB, Coles GA, Williams JD (1991) Subcutaneous
erythropoietin therapy: comparison of three different sites of injection.
Contrib Nephrol
88:
152-156
52 Jensen JD, Jensen LW, Madsen JK (1994) The pharmacokinetics of recombinant human erythro-
poietin after subcutaneous injection at different sites.
Eur J Clin Pharmacol
46: 333-337
53 Storring PL, Tiplady RJ, Gaines Das RE, Stenning BE, Lamikanra A, Rafferty B, Lee J (1998)
Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties.
Br J Haematol
100:79-89
54 Kato M, Kamiyama H, Okazaki A, Kumaki K, Kato Y, Sugiyama Y (1997) Mechanism for the
nonlinear pharmacokinetics of erythropoietin in rats.
J Pharmacol Exp Ther
283: 520-527
55 Spivak JL, Hogans BB (1989) The
in vivo
metabolism of recombinant human erythropoietin in the
rat.
Blood
73: 90-99
56 Macdougall IC, Gray SJ, Elston O, Breen C, Jenkins B, Browne J, Egrie J (1999)
Pharmaceokinetics of novel erythropoieis stimulating protein compared with epoetin alfa in dial-
ysis patients.
J Am Soc Nephrol
10: 2392-2395
